Abbreviations used: EArn, Maximal response; ECso, concentra tion producing the half-maximal response; 5-HT, 5-hydroxy tryptamine; pD2' negative logarithm of the ECso value; PGF"" , prostaglandin F "". 231 and 45.5% at 10-5 M, respectively. Statistically significant (p < 0.0 1) reactions were observed at 10-7 M and higher concentrations of bradykinin. The observed effects were independent of initial vessel size (80-260 /-Lm). These in situ findings are very similar to those found in vitro. The isolated guinea pig ileum was used to check the stability of the bradykinin solutions. In this instance, a concentration-dependent contraction was found when "freshly prepared" or "5 hours stored" bradykinin was applied, indicating no measurable degradation of bradykinin. We conclude that bradykinin is a powerful vasodilator of both human and feline pial arteries.
Effects of Bradykinin on Pial Arteries and Arterioles
In Vitro and In Situ *Michael Wahl, t Alan R. Young, :j:Lars Edvinsson, and *Franz Wagner Summary: The effect of bradykinin on cerebrovascular resistance vessels was investigated by the use of in vitro and in situ preparations. Bradykinin, in the range of 10-10 to 10-5 M, elicited a concentration-dependent vasodilata tion on both feline and human pial arteries in vitro; the half-maximal response was found to be approximately at 2.8 x 10-7 M and 1.3 x 10-8 M (EC5o), respectively. This dilatatory effect of bradykinin in vitro was found only in arteries pre constricted with prostaglandin F 2a or 5hydroxytryptamine. In order to determine the effects of bradykinin on the diameter of cat pial arteries in situ, perivascular microapplication was employed. The dose response curves obtained showed vasodilatation; the EC50 and the maximal response (EArn) were 4.4 x 10-7 M It has been established that several transmitters, such as noradrenaline, acetylcholine, histamine, serotonin, and dopamine can change vascular re sistance or cerebral blood flow (Edvinsson and MacKenzie, 1976; Kuschinsky and Wahl, 1978) . Yet another vasoactive agent, bradykinin, is known to occur in brain and blood (Rocha e Silva et aI. , 1949; Correa et aI., 1979) .
Bradykinin appears to be generated and released within the brain parenchyma in small amounts. Components of an intracerebral bradykinin system have been described previously. Kininogen-and kininogenase-like activity have been found in the brains of rabbits, rats, cattle, and bull-frogs (Hori, 1968; Shikimi et aI. , 1973) , although measurable amounts of kininogen could not be detected in the cortex of cats (Baethmann et aI. , 1981) . Kinin-like activity and immunoreactive bradykinin localized in the neuronal cells have been observed, primarily in the hypothalamus (Hori, 1968; Pela et aI., 1975) . However, bradykinin-containing fibres also exist in superficial layers of cerebral cortex (Correa et aI. , 1979) .
Bradykinin has been reported to exert constric tive as well as dilatory responses in many vas cular beds (Regoli and Barabe, 1980) . In an exten sive study using helical strips of arteries, Toda (1977) found various effects of bradykinin, depend ing on species and vascular bed. Whereas bradyki nin elicited contraction of canine cerebral arteries, it induced minimal dilatation in feline basilar artery but moderate and strong dilatation in cerebral ar teries from humans and rabbits, respectively. In order to characterize further the vasomotor effects of bradykinin, we have studied its actions on cere bral vessels in vitro and in situ.
EXPERIMENTAL PROCEDURES

Pial arteries in vitro
Preparation and recording of effects. Feline pial ves sels were obtained from eight adult cats of both sexes (2.0-3.5 kg body weight), which were exsanguinated under sodium pentobarbital anaesthesia (Nembutal®, 30 mg/kg, i.p.) . The brain was removed and placed into an ice-cold Krebs solution. The middle cerebral arteries and large pial arterioles from the fronto-parietal cortex were carefully removed with the aid of a dissection micro scope. The pial vessels were either used immediately or stored in the buffer solution at 4°C for up to 24 h.
Small segments of human pial arteries were removed from macroscopically normal parts of brain cortex during lobe resections in conjunction with neurosurgical tumour operations in three patients. Vessel segments were taken out together with small parts of underlying normal cortex and immediately immersed in ice-cold Krebs solution. The specimens were then transported rapidly to the labo ratory; the arteries were carefully dissected out and used immediately.
Arterial segments from cat and man, approximately 300-400 Mm in diameter and about 2-3 mm long, were suspended between two L-shaped metal prongs in 2.5-or 5.0-ml organ baths containing a Krebs solution that was aerated continuously with 95% 02/5% CO2 and main tained at 37°C. One of the two metal prongs was con nected to a force transducer (Grass FT03 C) for the re cording of isometric tension, and the other prong was fixed to a displacement device at the opposite side of the bath. Each vessel was given a tension of 3-4 mN and allowed to accommodate for 90-120 min, during which time the vessels were rinsed with fresh buffer solution every 15 min (for further details see Hogestatt et aI., 198 1) .
The contractile effect obtained by the depolarizing so lution (124 mM K+) was regarded as a measure of vessel reactivity. Prostaglandin F2u (PGF2u) or 5-hydroxytryp tamine (5-HT) were then administered to give a steady level of tension during which the dilatory effect of bradykinin could be examined. In these tests, the re sponses to PGF2<x or 5-HT were set at 100%, and the bradykinin response was expressed in relation to this in duced tension. Only one experiment was performed on each vessel segment because of the possibility of tachyphylaxis.
The responses were analysed further with regard to the concentration of the drug that produced the half-maximal response (EC5o) and the maximal response (EArn) that could be obtained. Calculations of the EC50 values were based on the geometrical means.
Solutions. The composition of the Krebs solution was (mM): NaCI, 119; NaHCOa, 15; KCI, 4.6; CaCI2, 1.5; NaH2P0 4 , 1.2; and glucose, 11. A high-potassium solu tion (124 mM K+) was obtained by exchanging NaCI in the Krebs solution with equimolar amounts of KCI. Statistical analyses. Student's t test and the sequen tially rejective Bonferroni procedure were used for statis tical analysis. The results are presented as the means ± SEM. In addition, 95% confidence limits are given.
Pial arteries in situ
Preparation and recording of effects. Experiments were performed on 13 cats of both sexes (2.6-4.5 kg body weight), which were anesthetized with a-chloralose (40-50 mg/kg, i.v.) and immobilized with gallamine (15-20 mg/kg·h, i.v.). The cats were ventilated artifi cially by means of a Bird Mark 8 respirator. Arterial pH and Pco2 and P02 were measured at 38°C with Radiometer BEU! and BMS2 equipment. The following values (means ± SD) were obtained: pH, 7.37 ± 0.03; Paco2, 29.5 ± 2.0 mm Hg; and Pao2, 137 ± 9 mm Hg. The value of the arterial Pco2 was close to that obtained in conscious cats J Cereb Blood Flow Metabol, Vol. 3, No.2, 1983 (Herbert and Mitchell, 1971 ). End-tidal CO2 (4.34 ± 0. 17 vol %), arterial pressure (100-160 mm Hg), and body temperature (37 -38°C) were recorded continuously. Only cats with a mean arterial pressure of > 100 mm Hg were used for the experiments. Tyrode' s solution (1.7 mllkg· h) was given intravenously to compensate for fluid loss during the experiments. The craniectomy was performed with a dental drill cooled with Tyrode's solution. The brain and dura were then covered with a 1 -2-cm thick layer of paraffin oil maintained at 37-38°C and, sub sequently, the dura was removed. The diameters of ar teries and arterioles of the parietal lobe were measured with an image-splitting method using a Bausch and Lomb stereo-zoom microscope, a 625-line Grundig television camera, and a Watanabe mUltiple channel pen recorder. The reproducibility of the method has been discussed previously in detail (Wahl et aI., 1973) .
Solutions. Bradykinin was dissolved in an inert mock cerebrospinal fluid (CSF) of the following composition (mM): Na+, 159.5; K+, 2.5; Ca 2 +, 1.5; Cl-, 150.5; and HCO" 3, 14.5, giving a pH of 7.25 (38°C) and an osmolarity of 308 mOsmollL. Bradykinin in concentrations up to 10-4 M did not change the pH or the osmolarity of the CSF solution. Under our experimental conditions, the values of pH and K+ of the mock spinal fluid are the same as those found in the natural CSF of the cortical sub arachnoid space (Kuschinsky and Wahl, 1979; Wahl and Kuschinsky, 1979a) . The osmolarity of the mock CSF is similar to that of the cisterna magna fluid, as sampled from an additional 20 cats and found to be 310 ± 3 (means ± SEM) mOsmollL. In comparison, the osmolarity of the plasma was 308 ± 3 mOsmollL. Fresh solutions were pre pared daily in polystyrol vials, bubbled with a mixture of 5% CO2 and 95% N2 (equilibrated with water), and kept at about O°C in a refrigerator. Glass capillaries with shar pened tips (8-10 Mm, outside diameter) were filled with the solutions immediately before use. To prevent absorp tion of bradykinin, the glass capillaries and pipettes were siliconized with a 1% solution of Vernetzer VP 1405 and finally washed with distilled water, 2-propanol, and ether.
The tip of the pipette was placed through the superficial layer of the arachnoid membrane, and 5 1£1 of the solution was injected into the perivascular space with a microper fusion pump. Measurements of vascular diameter were made prior to the injection, and at 20 and 40 s following application. The mean values of the latter two mea surements were used to calculate the change in vascular diameter induced by bradykinin. Before the definitive ex periment, the reactivity of each vessel to alterations in pH (Wahl et aI., 1970; Kuschinsky et aI., 1972) Statistical analyses. The statistical analysis of the data shown in Fig. 4 was performed by an analysis of variance and multiple comparisons according to the method of Scheffe (1953) .
Isolated guinea pig ileum
Preparation and recording of effects. The terminal ileum, excluding the distal 3 cm, was removed from un conscious female guinea pigs (300-400 g) and washed with a modified Krebs solution. Segments of ileum (2 cm long) were suspended in 5-ml organ baths at room tem perature. The specimens were given an initial tension of 7.5 mN; thereafter, the bath containing the Krebs solution was slowly warmed up to 37°C. An accommodation pe riod of 60-90 min was given to each ileum segment, dur ing which time the bath fluid was replaced every 15 min.
Isometric contractions were measured with a Hottinger Q 11/50 transducer, a Hottinger IG26 13 amplifier, and a Servogor recorder. The test solutions had the same ionic composition as the mock CSF and were treated and stored under identical conditions. This solution (0.08 ml), with or without bradykinin, was added to the organ bath; the solutions remained in this organ bath for a period of 2 min. Thereafter, the tissue was washed for 1 min with fresh Krebs solution and allowed to return to the resting tension. The response to bradykinin was taken as the dif ference between the resting tension and the mean peak response over a period of 15 s.
Solutions. The composition of the modified Krebs so lution (Handschumacher and Vane, 1967 ) was (mM):
Na+, 131; K+, 5.9; Mg 2 + , 1.2; Ca 2 +, 2.5; Cl-, 128; H2PO�-, 1.2; HCO:i, 25; glucose, 6. The solution was continu ously aerated with 95% O2/5% CO2, Statistical analsyes. The statistical evaluation was made by an analysis of variance and multiple comparisons according to the method of Scheffe (1953) . In addition, a paired t test, including the sequentially rejective Bonfer roni procedure, was employed to assure the multiple level of significance, according to the method of Holm (1979) .
Materials
The following drugs were purchased directly from the manufacturers: bradykinin triacetate (Serva or Sigma), PG F 2a (Amoglandin@; Astra), and 5-HT creatinine sul phate (Sigma). All drugs were analytical grade.
RESULTS
Pial arteries in vitro
Feline middle cerebral artery. Bradykinin had no effect on resting feline middle cerebral arteries (=400 JLm; Fig. 1, top) . Therefore, in order to reveal any vasodilatory action, the vessels were precon stricted by the addition of PGF2 a (3 x 10-6 M) or 5-HT (3 x 10-7 M) to the bathing medium. Both compounds induced a stable level of contraction that was found to be 3.4 ± 1.9 mN for PGF2 a and 2.6 ± 0.9 mN for 5-HT. Bradykinin was tested only once on each arterial segment by cumulative application. Under such conditions, bradykinin elicited in all vessels tested a con centration-dependent dilatation in the concentra tion range of IO-L 10-5 M (Fig. 1, bottom) . The degree of dilatation induced in the various vessels was variable, but obviously not influenced by the mode of precontraction induced by either PGF2a or 5-HT. The EC 5 0 was found to be 2.8 ± 1.6 x 10-7 M. The corresponding negative logarithm of the EC 5 0 value (pD2) was 6.55 ± 0.20, with 95% confidence limits of 6.98 and 6.12. The EArn was 50 ± 9%, with 95% confidence limits of 31 and 69% (Fig. 2) .
Feline pial arterioles. Experiments were carried out using a procedure identical to that described above. Although somewhat smaller in size «200 JLm), the large pial arterioles responded in a manner similar to that of the middle cerebral arteries men tioned above. The mean EC 5 0 obtained in these ves sels was 2.0 ± 2.7 x 10-7 M and was not signifi cantly different from that found in the segments of the middle cerebral artery. The corresponding pD2 was 6.69 ± 0.44, with 95% confidence limits of 7.82 and 5.56. The EArn was 72 ± 4%, with 95% confi dence limits of 62 and 82% (Fig. 2) . Human pial arteries. A similar testing procedure and preparation was used as described above for feline arteries. All six of the human pial arteries (=300 /Lm) obtained from three patients during neurosurgical operations responded with dilatation to bradykinin. The effects induced by 10-7-10-5 M bradykinin were significantly different from the re sponse obtained at 10-1 0 M. Although the magnitude of the response of human pial arteries was similar to that of feline vessels, the human arteries would ap pear to have a lower EC 5 0 value of 1.3 ± 1.7 x 10-8 M. The corresponding pD2 was 7.88 ± 0.22, with 95% confidence limits of 8.45 and 7.41. At a con centration of 10-5 M, an EArn of 48 ± 19%, with 95% confidence limits of 0 and 96, was found ( Fig. 3) .
Pial arteries and arterioles in situ
Perivascular application of mock CSF did not significantly alter the diameter of pial vessels (+0.478 ± 0.421%). The direct microinjection of bradykinin 00-1:3-10-4 M) around an artery resulted in a dose-dependent dilatation (Fig. 4) . Pial arterioles and arteries both showed a vasodilatation starting at 10-8 M. An EArn of 45.5% was obtained at 10-5 M bradykinin, and the EC 5 0 was found to be 4.4 x 10-7 M. A slight decrease in the dilatation was observed at 10-4 M bradykinin.
The vascular response started immediately after the microapplication and reached a steady state between 20 and 40 s following the injection. Upon removal of the micropipette, the vessel returned to its resting diameter within 1-5 min. Statistical analyses revealed that the dilatations evoked by bradykinin at concentrations of 10-7 M or greater were significantly different (p < 0.01) from the ef fect of the mock CSF alone. Starting at 10-7 M bradykinin, the reactions to each concentration were significantly different (p < 0.01) from each other, with the exceptions of 10-5 and 10-4 M. No indication of tachyphylaxis was found under our experimental conditions, as repeated applications (five times) of 10-6 or 10-5 M bradykinin elicited the same effect when the vascular diameter was al lowed to return to control after each application.
There is no obvious relation between resting ves sel diameter (80-260 /Lm) and reactivity to bradyki nin in concentrations of 10-7-10-5 M (Fig. 5) . Linear regressions were calculated for the vascular diameter during application of the three different concentrations of bradykinin. The following equa tions and correlation coefficients were obtained: y = 16.70 -0.03lx, and r = -0.164 for the data ob- 
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... :: tained at 10-7 M bradykinin; y = 45.48 -0.097x, and r = -0.259 for the data obtained at 10-6 M bradykinin; y = 60.51 -0.094x, and r = 0.276 for the data obtained at 10-5 M bradykinin. Although there is a minimal tendency for larger vessels to respond with a reduced dilatation to bradykinin (at least at 10-5 M), a significant correlation between vessel size and vascular response was not found for any one of the three groups. Guinea pig ileum. In order to check the stability of the solutions used, a guinea pig ileum smooth muscle preparation was run in parallel with the in situ studies. The same solutions used for the mi croapplication to pial arteries were tested on the iso lated guinea pig ileum. The sequence of testing the solutions was changed from experiment to experi ment; i.e., on the same ileum, the "freshly prepared" bradykinin was tested first and then the "5 hours stored" bradykinin, or vice versa. Appli cation of bradykinin elicited concentration dependent contractions of the ileum (Fig. 6) . The contraction started within 20 s after adding bradyki nin to the bath and reached a peak within 2 min. Contractions were statistically significant at 1.6 x 10-8 M to 1.6 X 10-6 M of bradykinin (p < 0.001). There was no significant difference between curves for the "freshly prepared" and the "5 hours stored" bradykinin when an analysis according to Holm (1979) was employed.
DISCUSSION
Bradykinin has been shown to elicit both con traction and relaxation of cerebral arteries in vitro from a variety of species, including man (Toda, 1977; Regoli and Barabe, 1980) . However, we have been unable to find any studies on the ef fect of bradykinin on the cerebrovascular bed in situ. Therefore, we have tested the effect of bradykinin on feline pial resistance vessels under in situ conditions. Considering the above-mentioned contradictory effects of bradykinin on isolated ves sels, we thought it worthwhile to characterize further the effects of bradykinin on feline and human cerebral arteries and large arterioles in vitro.
The present investigation revealed that bradyki nin induced a concentration-dependent relaxation when applied to isolated ring segments of cat middle cerebral arteries. The arteries examined were ap proximately 300-400 /Lm in diameter and were pre constricted by the addition of PGF2a or 5-HT. These data extend the findings by Toda (1977) , who showed, in vessels precontracted by potassium, that bradykinin induced slight dilatations in a part of the feline basilar arteries tested. In contradistinction, Hanko and co-workers (1981) reported that bradykinin induced a vasoconstriction of cat middle cerebral arteries that were not precontracted. The latter findings are in direct contrast to the present observations. However, since the presence of an intact endothelial cell layer is necessary to obtain relaxation by bradykinin in several arteries (Cherry et aI., 1982) , accidental or unintentional damage of the endothelial cells may result in a modified re sponse .
The direct vascular effects of bradykinin on human pial arteries (300 /Lm) were found to be sim ilar to those of the feline vessels: namely a concentration-dependent relaxation was obtained on vessels preconstricted by PGF2a• The same ef fect was observed by Toda (1977) when potassium or PGF2a was used to preconstrict strips of human cerebral arteries.
Our results on the effects of bradykinin under in vitro conditions are completely in accordance with the actions of this nonapeptide in more physiologi cal conditions, e.g., microapplication on feline pial arteries and arterioles in situ.
Bradykinin elicited a dilatation in the same con centration range (10-8-10-4 M) as that found in in vitro studies. Although bradykinin has the same potency as adenosine (EC50, 7.4 x 10-7 M) or his tamine (EC50, 9.95 x 10-7 M)-which were tested by the same technique and experimental conditions (Wahl and Kuschinsky, 1976;  Wahl and Kus chinsky, 1979b )-the maximal dilatation induced by bradykinin was more pronounced. Furthermore, the initial vessel calibre (80-260 j.tm) did not influ ence the response to bradykinin. That the vascular reaction is independent of the vessel size has al ready been found during microapplication of other cerebral vasodilatory agents, such as low-pH so lutions (Kuschinsky et al., 1972) , adenosine (Wahl and Kuschinsky, 1976) , and histamine (Wahl and Kuschinsky, 1979b) .
It is well known that bradykinin induces an in crease in blood flow in several organs, as has been reported for myocardial blood flow (Parratt, 1964) . However, no literature is available at present on the effects of bradykinin on cerebral blood flow. Kariya and others (1981) have demonstrated that the intra cerebral administration of bradykinin induced an increase in the activity of the electroencephalogram (EEG) recording and provoked behavioral changes in unrestrained rats. This situation might be accom panied by an increase in cerebral bloow flow. Such an assumption is supported by our present findings and the coupling between EEG frequency and cere bral blood flow, which has been reviewed by Paul son and Sharbrough (1974) .
The findings obtained on the isolated guinea pig ileum are in accordance with the results reported by others (Hori, 1968; Camargo et al. , 1973; Roberts, 1980) . Since Camargo and co-workers (1973) found that fragments of bradykinin induce a negligible contraction of the guinea pig ileum, it is evident that the effects measured are really due to bradykinin and not to a product of catabolism. Bradykinin, dis solved in mock CSF and stored under our experi mental conditions, did not lose its biological activity throughout the period of the experiment, since the concentration-response curves for "freshly pre pared" and" 5 hours stored" bradykinin are not statistically different from each other.
In conclusion, we believe that the effects of bradykinin on human and feline cerebral resistance vessels are predominantly dilatory. In situ, brady kinin would appear to be a more powerful vaso dilator than either adenosine or histamine. The physiological importance of bradykinin in the cere bral circulation requires and deserves further elab oration. 
